TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 73.40
+0.40 (0.55%)
May 29, 2026, 1:30 PM CST
TTY Biopharm Company Market Cap
TTY Biopharm Company has a market cap or net worth of 18.25 billion as of May 29, 2026. Its market cap has decreased by -3.67% in one year.
Market Cap
18.25B
Enterprise Value
17.32B
Revenue
6.51B
Ranking
n/a
PE Ratio
11.94
Stock Price
73.40
Market Cap Chart
Since July 3, 2003, TTY Biopharm Company's market cap has increased from 3.05B to 18.25B, an increase of 498.55%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 18.25B | -9.94% |
| Dec 31, 2025 | 20.26B | 11.95% |
| Dec 31, 2024 | 18.10B | -9.45% |
| Dec 29, 2023 | 19.99B | -3.60% |
| Dec 30, 2022 | 20.74B | 21.22% |
| Dec 30, 2021 | 17.11B | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 51.25B |
| Bora Pharmaceuticals | 43.94B |
| Center Laboratories | 28.55B |
| ScinoPharm Taiwan | 15.62B |
| Synmosa Biopharma | 15.16B |
| Grape King Bio | 14.96B |
| YungShin Global Holding | 14.86B |
| Foresee Pharmaceuticals | 12.13B |